Project title
開發新穎蛋白候選藥物---去組合蛋白αvβ3抑制劑PEG–ARLDDL 之新抗癌用途(I)
Internal ID
NSC100-2325-B002-022
Principal Investigator
Start Date
May 1, 2011
End Date
April 12, 2012
Partner Organizations
(100CA021)Development of New Anti-Cancer Indications for Protein Drug Candidate of Αvβ3 Antagonist–PEG–ARLDDL (I)
Keywords
造骨蛋白
抗藥性
p-glycoprotein醣蛋白
攝護腺癌
組合蛋白
osteopontin
drug resistance
p-glycoprotein
PC-3
αvβ3 integrin
chemotherapy
ARLDDL